Drug Shortage Report for RIVASTIGMINE

Last updated on 2024-11-29 History
Report ID 244190
Drug Identification Number 02417006
Brand name RIVASTIGMINE
Common or Proper name RIVASTIGMINE
Company Name PRO DOC LIMITEE
Market Status MARKETED
Active Ingredient(s) RIVASTIGMINE
Strength(s) 3MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-03-31
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2024-11-29
Company comments Looking to transfert to another supplier
Health Canada comments
Tier 3 Status No
Contact Address 2925 BOULEVARD INDUSTRIEL
LAVAL, QUEBEC
CANADA H7L 3W9
Company contact information 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2024-11-29 French Compare
v1 2024-11-29 English Compare

Showing 1 to 2 of 2